1. Executive Summary
2. Research Methodology
3. Radiopharmaceutical
3.1 Overview
3.1.1 Market Evolution
3.2 Category
3.3 Applications
3.3.1 Therapeutic Uses
3.3.2 Orthopedics
3.3.3 Oncology
3.3.4 Radiosynoviorthesis
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market Share by Radioisotope
4.2.3 Market Share by Source
4.2.4 Market Share by Application
4.2.5 Market Share by Region
5. Market Segmentation
5.1 Diagnostics
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Products
5.2 Therapeutics
5.2.1 Market Sizing (Actual & Forecasted)
5.2.2 Market Share by Products
6. Regional Analysis
6.1 North America
6.1.1 The US
6.1.1.1 Market Sizing (Actual & Forecasted)
6.1.1.2 Market Share by Products
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Products
6.2.3 The UK
6.2.3.1 Market Sizing (Actual & Forecasted)
6.2.4 Germany
6.2.4.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 Market Sizing (Actual & Forecasted)
6.3.3 Japan
6.3.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Development
7.1.1 Adoption of New Radiopharmaceuticals for Molecular Imaging
7.1.2 Fusion Imaging
7.2 Growth Drivers
7.2.1 Higher Incidence of Chronic Diseases
7.2.2 Prevalence of Cancer and Cardiac Ailments
7.2.3 Increasing Awareness of Radiopharmaceuticals
7.3 Challenges
7.3.1 Stringent Regulatory Norms
7.3.2 Scarcity of Radioisotopes
7.3.3 High Cost of Procedure
8. Competitive Landscape
8.1 Financial Analysis
8.2 Market Share by Competitors
9. Company Profiles
9.1 Siemens Healthineers AG
9.2 GE Healthcare
9.3 IBA RadioPharma Solutions
9.4 Lantheus Holdings, Inc.
9.5 Eckert & Ziegler
List of Tables
Table 1: Applications of Radiopharmaceuticals in Healthcare
Table 2: Global Radiopharmaceutical Companies Financial Analysis (2018)
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Emission of Radiation from Radionuclide
Figure 3: Global Radiopharmaceutical Market Size by Value, 2010-18E (US$ Billions)
Figure 4: Global Radiopharmaceutical Market Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 5: Global Radiopharmaceutical Market Share by Products (2017)
Figure 6: Global Radiopharmaceutical Market Share by Type of Radioisotope (2017)
Figure 7: Global Radiopharmaceutical Market Share by Source (2017)
Figure 8: Global Radiopharmaceutical Market Share by Application (2017)
Figure 9: Global Radiopharmaceutical Market Share by Region (2017)
Figure 10: Global Radiopharmaceutical – Diagnostics Market Size by Value, 2012-18E (US$ Billions)
Figure 11: Global Radiopharmaceutical – Diagnostics Market Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 12: Global Radiopharmaceuticals – Diagnostics Market Share by Products (2017)
Figure 13: Global Radiopharmaceutical – Therapeutics Market Size by Value, 2012-18E (US$ Billions)
Figure 14: Global Radiopharmaceutical – Therapeutics Market Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 15: Global Radiopharmaceuticals – Therapeutics Market Share by Products (2017)
Figure 16: North America Radiopharmaceutical Market Size by Value, 2015-24E (US$ Billions)
Figure 17: The US Radiopharmaceutical Market Size by Value, 2013-18E (US$ Billions)
Figure 18: The US Radiopharmaceutical Market Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 19: The US Radiopharmaceutical Market Share by Products (Diagnostics/Therapeutics), 2013-24E
Figure 20: Europe Radiopharmaceutical Market Size by Value, 2015-24E (US$ Billions)
Figure 21: Europe Radiopharmaceutical Market Share by Products (2017)
Figure 22: The UK Radiopharmaceutical Market Size by Value, 2015-24E (US$ Millions)
Figure 23: The UK Radiopharmaceutical Market Size by Value, 2015-24E (US$ Millions)
Figure 24: Asia Pacific Radiopharmaceutical Market Size by Value, 2015-24E (US$ Billions)
Figure 25: China Radiopharmaceutical Market Size by Value, 2017-24E (US$ Millions)
Figure 26: Japan Radiopharmaceutical Market Size by Value, 2017-24E (US$ Millions)
Figure 27: Global Chronic Disease Incidences, 2013-17 (Millions)
Figure 28: Global Cancer and Cardiac Disease Incidence, 2012-17 (Millions)
Figure 29: Global Radiopharmaceutical Market Share by Competitors (2017)
Figure 30: Siemens Healthineers AG Revenue by Business Segment (FY2017)
Figure 31: Siemens Healthineers AG Net Sales, FY2013-FY2018 (US$ Billions)
Figure 32: GE Healthcare Revenue by Business Segment (FY2017)
Figure 33: GE Healthcare Net Sales, FY2013-FY2017 (US$ Billions)
Figure 34: IBA Group Revenue by Business Segment (FY2017)
Figure 35: IBA Group Net Sales, FY2013-FY2017 (US$ Millions)
Figure 36: Lantheus Holdings, Inc. revenue by Business Segment (FY2017)
Figure 37: Lantheus Holdings, Inc. Net Sales, FY2013-FY2017 (US$ Millions)
Figure 38: Eckert & Ziegler Revenue by Business Segment (FY2017)
Figure 39: Eckert & Ziegler Net Sales, FY2013-FY2017 (US$ Millions)
Siemens Healthineers AG, GE Healthcare, IBA RadioPharma Solutions, Lantheus Holdings, Inc. and Eckert & Ziegler.
*If Applicable.